ADUS vs TECH · P/E 17, rev $1.15B vs P/E 65, rev $1.22B
Addus HomeCare Corporation (ADUS) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Addus HomeCare Corporation (ADUS) is a medical care facilities company listed on NASDAQ.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported ADUS revenue for 2024-12-31 was $1.15B. Net income was $73.6M. Revenue was up 9.1% from 2023-12-31 to 2024-12-31. ADUS currently screens at market cap $1.75B and trailing P/E 17.3.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
ADUS currently screens at market cap $1.75B and trailing P/E 17.3. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the ADUS and TECH stock pages for the full models.
Not investment advice.